Loading...
Loading...
Universe Pharmaceuticals INC
Universe Pharmaceuticals INC. Spoken Alpha tracks UPC's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks UPC's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for UPC.
curl https://api.spokenalpha.com/v1/companies/UPC| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $6.20 | $4.51 | +37.4% | +0.1% | -1.2% |
| Q4 FY2026 | $6.25 | $4.30 | +45.4% | +1.5% | -0.3% |
| Q3 FY2026 | $6.10 | $4.32 | +41.2% | -8.4% | -11.2% |
| Q2 FY2026 | $6.12 | $4.39 | +39.5% | -3.6% | -4.3% |
| Q1 FY2025 | $6.40 | $4.39 | +45.7% | +1.3% | -0.5% |
| Q4 FY2025 | $6.19 | $4.34 | +42.6% | +0.2% | -1.8% |
| Q3 FY2025 | $6.72 | $4.52 | +48.6% | -2.2% | -3.8% |
| Q2 FY2025 | $6.29 | $4.40 | +43.0% | -2.6% | -4.3% |
| Q1 FY2024 | $6.53 | $4.42 | +47.7% | -5.7% | -7.7% |
| Q4 FY2024 | $6.32 | $4.47 | +41.3% | -2.4% | -3.5% |